CBD oil has been studied for its potential role in relieving symptoms of many common health problems, such as anxiety, depression, acne and heart disease. For cancer patients, it may even provide a natural alternative for pain and symptom relief. Another concern is the unreliability of the purity and dosage of CBD in products. A recent study of 84 CBD products purchased online showed that more than a quarter of the products contained less CBD than labelled.
In addition, THC was found in 18 products. As with most therapies, the use of CBD can carry some risks. It can interact with supplements and other medications. Most CBD products are not FDA-approved, which also means that they have not been thoroughly tested.
The health benefits of CBD cover a variety of conditions. It is most commonly used to treat chronic pain, anxiety, inflammation and insomnia. Overall, the FDA said it has been unable to conclude that CBD is safe for use in animal or human food, and noted that the sale of food or beverages containing CBD is illegal in the United States. Before deciding whether to take CBD supplements, talk to your doctor to determine how CBD may affect you, and be aware that the advertising claims for most CBD products are unproven.
The FDA is raising new safety concerns about cannabidiol (CBD)-containing products, particularly CBD-containing foods, and last week sent warning letters to 15 companies the agency says are illegally marketing CBD products. In addition, animal studies have found that CBD may have anti-inflammatory effects that can treat chronic pain or inflammatory diseases in animals, and other limited research indicates that CBD may help treat psychological disorders. Last week, the FDA revised a consumer update outlining the agency's new concerns about CBD products, and in particular about foods containing CBD. The agency noted that its own testing has shown that some products do not contain the amounts of CBD they claim to contain, while some CBD products contain toxic metals, pesticides and THC.
The FDA has mistakenly substituted the adverse effects of Epidiolex, a refined, isolated, semi-synthetic form of CBD, for the same form of CBD sold by those in the nutritional supplement industry, Titus said. But Stuart Titus-CEO of Medical Marijuana, which is involved with CBD products in the US-raised concerns about the FDA's update, saying it confuses the side effects of Epidiolex with general CBD products. There is no evidence that botanical forms of CBD have any more "drug interaction" than regular food or that the natural botanical form of CBD confers the "liver toxic effects" the FDA mentions in its statement. Worse, CBD is being produced without any regulation, resulting in products that vary widely in quality, said Marcel Bonn-Miller, associate professor of psychology in psychiatry at the University of Pennsylvania School of Medicine.
Joe Bob, who starts a CBD company, can put whatever he wants on a label and sell it to people. The Food and Drug Administration (FDA) advisory panel unanimously recommended approval of the CBD drug Epidiolex to treat two rare forms of childhood epilepsy. For example, some human clinical trials suggest that CBD may be effective in treating symptoms of anxiety, particularly social anxiety, Bonn-Miller said.